Research suggests that GLP-1 weight-loss drugs may have a potential role in addressing addiction. Studies indicate that these drugs could be linked to lower risks of addiction and overdose, and may even prevent cravings from forming. The scope of their potential impact is still being explored, with some studies investigating their effect on a range of substances, including alcohol.